Nanomega CryoAI
Nanomega CryoAI helps researchers accelerate drug discovery using CryoEM and AI. It combines structural biology with deep learning and high-performance computing to deliver integrated CryoEM and AI drug design services. The company serves biopharmaceutical customers and research labs pursuing small molecules, antibodies, protein degradation, and gene therapy solutions. Key technologies include CryoEM, deep learning, HPC, and data processing pipelines. The company targets the global pharma market and aims to scale with continued innovation in structural biology and drug development.
Nanomega CryoAI
Nanomega CryoAI helps researchers accelerate drug discovery using CryoEM and AI. It combines structural biology with deep learning and high-performance computing to deliver integrated CryoEM and AI drug design services. The company serves biopharmaceutical customers and research labs pursuing small molecules, antibodies, protein degradation, and gene therapy solutions. Key technologies include CryoEM, deep learning, HPC, and data processing pipelines. The company targets the global pharma market and aims to scale with continued innovation in structural biology and drug development.